Author: Armbruster, Walter J.; Roberts, Tanya
Title: The Political Economy of US Antibiotic Use in Animal Feed Cord-id: dd5gw66t Document date: 2018_5_30
ID: dd5gw66t
Snippet: This chapter examines the evidence for antibiotic resistance in the United States and globally, the public health implications, and the impact of—and related industry and political responses to—antibiotic use in animal feed. In 1969, the Swann Report in the United Kingdom noted a dramatic increase in antibiotic-resistant bacteria in food animals receiving low levels of antibiotics in their feed. While the Food and Drug Administration of the United States sought to control antibiotics in anim
Document: This chapter examines the evidence for antibiotic resistance in the United States and globally, the public health implications, and the impact of—and related industry and political responses to—antibiotic use in animal feed. In 1969, the Swann Report in the United Kingdom noted a dramatic increase in antibiotic-resistant bacteria in food animals receiving low levels of antibiotics in their feed. While the Food and Drug Administration of the United States sought to control antibiotics in animal feed as far back as 1977, only in 2016 were such regulations fully implemented. The farm-level costs of such controls are estimated by the US Department of Agriculture’s Economic Research Service to be minimal, while the Centers for Disease Control and Prevention’s estimates of the public health costs of antibiotic resistance without implementing controls are $7 billion annually. The complex interactions which exist between economic interests, regulatory policy, and human and animal health are explored in this chapter.
Search related documents:
Co phrase search for related documents- accuracy precision and acute disease: 1, 2, 3, 4, 5, 6
- action plan and acute disease: 1
- action plan and additional cost: 1
- actionable knowledge and acute disease: 1, 2
- active infection and acute disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- active ingredient and acute disease: 1, 2, 3, 4
- active ingredient and additional harm: 1
- acute disease and additional cost: 1
Co phrase search for related documents, hyperlinks ordered by date